Insider Trading & Ownership of Catherine M. Burzik
-
Summary
-
The estimated net worth of Catherine M. Burzik is at least $6,717,040 dollars as of 30 Jan 2025. Catherine M. Burzik is the Director of BECTON DICKINSON & CO and owns shares of BECTON DICKINSON & CO (BDX) stock worth about $3.42M. Catherine M. Burzik is the Director of HAEMONETICS CORP and owns shares of HAEMONETICS CORP (HAE) stock worth about $1.69M. Catherine M. Burzik is the Director of Orthofix Medical Inc. and owns shares of Orthofix Medical Inc. (OFIX) stock worth about $1.61M.
-
Signature
-
Donna Kalazdy, by power of attorney for Catherine M. Burzik
Follow Filing Activity
Follow Catherine M. Burzik and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Quick Takeaways
- Catherine M. Burzik has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $6,717,040.
- Recent insider filing activity is available below.
What Changed
- Largest disclosed position: BECTON DICKINSON & CO ($3,423,360).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Continue ownership research
Ownership of Catherine M. Burzik
Insider Transactions Reported by Catherine M. Burzik:
| Sym |
Company |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.